482 related articles for article (PubMed ID: 23812558)
1. Cardioprotective functions of HDLs.
Rye KA; Barter PJ
J Lipid Res; 2014 Feb; 55(2):168-79. PubMed ID: 23812558
[TBL] [Abstract][Full Text] [Related]
2. Current Therapies Focused on High-Density Lipoproteins Associated with Cardiovascular Disease.
Estrada-Luna D; Ortiz-Rodriguez MA; Medina-Briseño L; Carreón-Torres E; Izquierdo-Vega JA; Sharma A; Cancino-Díaz JC; Pérez-Méndez O; Belefant-Miller H; Betanzos-Cabrera G
Molecules; 2018 Oct; 23(11):. PubMed ID: 30360466
[TBL] [Abstract][Full Text] [Related]
3. Dysfunctional high-density lipoproteins in children with chronic kidney disease.
Kaseda R; Jabs K; Hunley TE; Jones D; Bian A; Allen RM; Vickers KC; Yancey PG; Linton MF; Fazio S; Kon V
Metabolism; 2015 Feb; 64(2):263-73. PubMed ID: 25467845
[TBL] [Abstract][Full Text] [Related]
4. HDL-C: role as a risk modifier.
Barter P
Atheroscler Suppl; 2011 Nov; 12(3):267-70. PubMed ID: 22152280
[TBL] [Abstract][Full Text] [Related]
5. High-density lipoproteins in the prevention of cardiovascular disease: changing the paradigm.
Tuteja S; Rader DJ
Clin Pharmacol Ther; 2014 Jul; 96(1):48-56. PubMed ID: 24713591
[TBL] [Abstract][Full Text] [Related]
6. HDL in the 21st Century: A Multifunctional Roadmap for Future HDL Research.
Rohatgi A; Westerterp M; von Eckardstein A; Remaley A; Rye KA
Circulation; 2021 Jun; 143(23):2293-2309. PubMed ID: 34097448
[TBL] [Abstract][Full Text] [Related]
7. Current Understanding of the Relationship of HDL Composition, Structure and Function to Their Cardioprotective Properties in Chronic Kidney Disease.
Marsche G; Heine GH; Stadler JT; Holzer M
Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32967334
[TBL] [Abstract][Full Text] [Related]
8. Regulation of high-density lipoprotein metabolism.
Rye KA; Barter PJ
Circ Res; 2014 Jan; 114(1):143-56. PubMed ID: 24385508
[TBL] [Abstract][Full Text] [Related]
9. Mediterranean Diet Improves High-Density Lipoprotein Function in High-Cardiovascular-Risk Individuals: A Randomized Controlled Trial.
Hernáez Á; Castañer O; Elosua R; Pintó X; Estruch R; Salas-Salvadó J; Corella D; Arós F; Serra-Majem L; Fiol M; Ortega-Calvo M; Ros E; Martínez-González MÁ; de la Torre R; López-Sabater MC; Fitó M
Circulation; 2017 Feb; 135(7):633-643. PubMed ID: 28193797
[TBL] [Abstract][Full Text] [Related]
10. The pleiotropic effects of high-density lipoproteins and apolipoprotein A-I.
Thomas SR; Zhang Y; Rye KA
Best Pract Res Clin Endocrinol Metab; 2023 May; 37(3):101689. PubMed ID: 36008277
[TBL] [Abstract][Full Text] [Related]
11. High density lipoproteins and endothelial functions: mechanistic insights and alterations in cardiovascular disease.
Riwanto M; Landmesser U
J Lipid Res; 2013 Dec; 54(12):3227-43. PubMed ID: 23873269
[TBL] [Abstract][Full Text] [Related]
12. New roles of HDL in inflammation and hematopoiesis.
Zhu X; Parks JS
Annu Rev Nutr; 2012 Aug; 32():161-82. PubMed ID: 22540255
[TBL] [Abstract][Full Text] [Related]
13. Altered HDL metabolism in metabolic disorders: insights into the therapeutic potential of HDL.
Hui N; Barter PJ; Ong KL; Rye KA
Clin Sci (Lond); 2019 Nov; 133(21):2221-2235. PubMed ID: 31722013
[TBL] [Abstract][Full Text] [Related]
14. The rationale for using apoA-I as a clinical marker of cardiovascular risk.
Barter PJ; Rye KA
J Intern Med; 2006 May; 259(5):447-54. PubMed ID: 16629850
[TBL] [Abstract][Full Text] [Related]
15. Antiatherogenic properties of high-density lipoproteins from arterial plasma are attenuated as compared to their counterparts of venous origin.
Bonnefont-Rousselot D; Benouda L; Bittar R; Darabi-Amin M; Demondion P; Lesnik P; Leprince P; Kontush A; Charniot JC; Giral P
Nutr Metab Cardiovasc Dis; 2020 Jan; 30(1):33-39. PubMed ID: 31753791
[TBL] [Abstract][Full Text] [Related]
16. High-density lipoproteins, inflammation and oxidative stress.
Tabet F; Rye KA
Clin Sci (Lond); 2009 Jan; 116(2):87-98. PubMed ID: 19076062
[TBL] [Abstract][Full Text] [Related]
17. Effect of high-density lipoproteins on the expression of adhesion molecules in endothelial cells.
Barter PJ; Baker PW; Rye KA
Curr Opin Lipidol; 2002 Jun; 13(3):285-8. PubMed ID: 12045398
[TBL] [Abstract][Full Text] [Related]
18. Biological activities of HDL subpopulations and their relevance to cardiovascular disease.
Camont L; Chapman MJ; Kontush A
Trends Mol Med; 2011 Oct; 17(10):594-603. PubMed ID: 21839683
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers associated with high-density lipoproteins in atherosclerotic kidney disease.
Rye KA
Clin Exp Nephrol; 2014 Apr; 18(2):247-50. PubMed ID: 24052156
[TBL] [Abstract][Full Text] [Related]
20. HDL and atherosclerosis: Insights from inherited HDL disorders.
Calabresi L; Gomaraschi M; Simonelli S; Bernini F; Franceschini G
Biochim Biophys Acta; 2015 Jan; 1851(1):13-8. PubMed ID: 25068410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
